Zhangjiang Hi-Tech Park Development Co. of Shanghai will invest another 48 million RMB ($7 million) in its venture capital subsidiary, Haocheng Venture Capital Co. so that Haocheng can purchase a .4% stake in Shandong Buchang Pharmaceutical Co. Zhangjiang will purchase the shares from Shenzhen China Euro Capital Co. They carry a provision requiring Shenzhen China Euro to take back the shares if Buchang Pharma does not list its shares by the end of 2013. More details...